Top 10 Biotechnology Companies in 2024

Companies	Employees	HQ location	Revenue	Website	Industry
Roche	View 48,537 employees	🇨🇭 Switzerland, Basel	$ 1B+	roche.com	Health Care, Pharmaceutical, Medical, Biotechnology
Novartis	View 55,783 employees	🇨🇭 Switzerland, Basel	$ 1B+	novartis.com	Health Care, Biotechnology, Medical, Pharmaceutical, Biopharma
Labcorp	View 27,531 employees	🇺🇸 USA, NC, Burlington	$ 1B+	labcorp.com	Health Care, Medical, Clinical Trials, Pharmaceutical, Biotechnology, Health Diagnostics
Thermo Fisher Scientific	View 59,928 employees	🇺🇸 USA, MA, Waltham	$ 1B+	thermofisher.com	Biotechnology, Life Science, Manufacturing
Pfizer	View 72,467 employees	🇺🇸 USA, NY, New York	$ 1B+	pfizer.com	Biotechnology, Health Care, Pharmaceutical, Medical, Biopharma, Life Science
GSK	View 69,236 employees	🇬🇧 United Kingdom, Brentford	$ 1B+	gsk.com	Health Care, Biotechnology, Pharmaceutical, Life Science, Medical
Merck	View 17,498 employees	🇺🇸 USA, NJ, Rahway	$ 1B+	merck.com	Health Care, Biotechnology, Medical, Pharmaceutical, Life Science, Non Profit
IQVIA	View 62,125 employees	🇺🇸 USA, NC, Durham	$ 500M – $ 1B	iqvia.com	Health Care, Analytics, Predictive Analytics, Artificial Intelligence, Biotechnology, Life Science, Pharmaceutical, Clinical Trials, Machine Learning
AstraZeneca	View 55,738 employees	🇬🇧 United Kingdom, Cambridge	$ 1B+	astrazeneca.com	Biotechnology, Health Care, Medical, Pharmaceutical, Biopharma, Life Science
Siemens Healthineers	View 35,158 employees	🇩🇪 Germany, Erlangen	$ 500M – $ 1B	siemens-healthineers.com	Health Care, Medical, Medical Device, Health Diagnostics, Biotechnology, Neuroscience

1. Roche

Roche is a global healthcare leader focused on pharmaceuticals and diagnostics, dedicated to advancing personalized medicine. With a strong emphasis on innovation and research, Roche develops cutting-edge treatments and diagnostic tools that improve patient outcomes, particularly in oncology, immunology, and infectious diseases. The company’s integrated approach to healthcare combines pharmaceuticals and diagnostics, enabling more precise, tailored treatments. By continuously investing in R&D and fostering partnerships with healthcare providers, Roche is committed to shaping the future of medicine and addressing unmet medical needs worldwide.

Location 🇨🇭 Switzerland, Basel	Size View 48,537 employees
Revenue $ 1B+	Industries Health Care, Pharmaceutical, Medical, Biotechnology
	View Similar Companies

2. Novartis

Novartis is a global healthcare company known for pioneering innovative medicines that address serious diseases across multiple therapeutic areas, including oncology, immunology, and neuroscience. With a strong commitment to research and development, Novartis focuses on advancing cutting-edge treatments like gene therapies and targeted therapies that transform patient care. The company also integrates digital technology and data science to accelerate drug discovery and improve healthcare outcomes. Novartis is dedicated to improving and extending lives, making significant strides in tackling some of the world’s most pressing health challenges.

Location 🇨🇭 Switzerland, Basel	Size View 55,783 employees
Revenue $ 1B+	Industries Health Care, Biotechnology, Medical, Pharmaceutical, Biopharma
	View Similar Companies

3. Labcorp

Labcorp is a global life sciences company specializing in diagnostics, drug development, and laboratory services. Through its comprehensive testing capabilities, Labcorp provides healthcare providers with critical insights to diagnose, treat, and monitor patient health. The company also supports pharmaceutical and biotech firms by delivering end-to-end clinical trial management and drug development services. With a focus on innovation and scientific expertise, Labcorp plays a key role in advancing personalized medicine and improving health outcomes worldwide.

Location 🇺🇸 USA, NC, Burlington	Size View 27,531 employees
Revenue $ 1B+	Industries Health Care, Medical, Clinical Trials, Pharmaceutical, Biotechnology, Health Diagnostics
	View Similar Companies

4. Thermo Fisher Scientific

Thermo Fisher Scientific is a global leader in serving science, providing a wide range of products and services that support research, diagnostics, and manufacturing in various industries. From laboratory equipment and chemicals to advanced analytical tools and software, Thermo Fisher enables scientific advancements across life sciences, healthcare, and applied markets. The company also plays a critical role in supporting pharmaceutical development, including biologics and vaccines, by offering end-to-end solutions. With a mission to make the world healthier, cleaner, and safer, Thermo Fisher empowers scientists to accelerate breakthroughs in research and medicine.

Location 🇺🇸 USA, MA, Waltham	Size View 59,928 employees
Revenue $ 1B+	Industries Biotechnology, Life Science, Manufacturing
	View Similar Companies

5. Pfizer

Pfizer is a global pharmaceutical company renowned for its innovative medicines and vaccines that address some of the most critical health challenges. With a strong focus on research and development, Pfizer has pioneered treatments across areas like oncology, immunology, and infectious diseases. The company’s rapid development of the COVID-19 vaccine highlighted its leadership in scientific innovation and global healthcare. By collaborating with governments and healthcare providers, Pfizer is committed to ensuring access to life-saving therapies and improving patient outcomes worldwide.

Location 🇺🇸 USA, NY, New York	Size View 72,467 employees
Revenue $ 1B+	Industries Biotechnology, Health Care, Pharmaceutical, Medical, Biopharma, Life Science
	View Similar Companies

6. GSK

GSK is a global biopharma company focused on developing innovative vaccines and specialty medicines to tackle major diseases, including infectious diseases, HIV, oncology, and respiratory conditions. With a strong emphasis on research and development, GSK leverages cutting-edge science and technology to address unmet medical needs and improve patient outcomes. The company’s robust pipeline of vaccines and therapies reflects its commitment to prevention and long-term health solutions. GSK’s strategic focus on innovation and global health partnerships helps advance its mission of positively impacting lives around the world.

Location 🇬🇧 United Kingdom, Brentford	Size View 69,236 employees
Revenue $ 1B+	Industries Health Care, Biotechnology, Pharmaceutical, Life Science, Medical
	View Similar Companies

7. Merck

Merck, known as MSD outside the U.S. and Canada, is a global healthcare leader focused on delivering innovative medicines, vaccines, and therapies. With a strong emphasis on research and development, Merck addresses critical health challenges across areas like oncology, infectious diseases, cardiology, and animal health. The company’s groundbreaking work in immunotherapy and vaccines, including its contributions to cancer treatment, highlights its commitment to improving patient outcomes. Through partnerships and a relentless focus on innovation, Merck is dedicated to making a lasting impact on global health.

Location 🇺🇸 USA, NJ, Rahway	Size View 17,498 employees
Revenue $ 1B+	Industries Health Care, Biotechnology, Medical, Pharmaceutical, Life Science, Non Profit
	View Similar Companies

8. IQVIA

IQVIA is a global leader in advanced analytics, technology solutions, and clinical research services for the life sciences industry. By integrating extensive healthcare data with cutting-edge technology, IQVIA helps pharmaceutical, biotech, and healthcare companies accelerate drug development, optimize clinical trials, and enhance patient outcomes. The company’s AI-driven insights and real-world data solutions enable more precise decision-making throughout the drug lifecycle, from R&D to commercialization. With a strong focus on innovation and collaboration, IQVIA empowers organizations to navigate complex healthcare landscapes and bring new treatments to market faster.

Location 🇺🇸 USA, NC, Durham	Size View 62,125 employees
Revenue $ 500M – $ 1B	Industries Health Care, Analytics, Predictive Analytics, Artificial Intelligence, Biotechnology, Life Science, Pharmaceutical, Clinical Trials, Machine Learning
	View Similar Companies

9. AstraZeneca

AstraZeneca is a global biopharmaceutical company focused on the discovery, development, and commercialization of innovative medicines, particularly in oncology, cardiovascular, renal, and respiratory diseases. With a strong commitment to scientific research, AstraZeneca has a robust pipeline of therapies aimed at addressing unmet medical needs. The company’s leadership in precision medicine and biologics has made significant strides in improving patient outcomes. By combining cutting-edge science with strategic partnerships, AstraZeneca continues to advance healthcare and drive innovation across the global medical community.

Location 🇬🇧 United Kingdom, Cambridge	Size View 55,738 employees
Revenue $ 1B+	Industries Biotechnology, Health Care, Medical, Pharmaceutical, Biopharma, Life Science
	View Similar Companies

10. Siemens Healthineers

Siemens Healthineers is a global leader in medical technology, providing innovative solutions in diagnostics, imaging, and advanced therapies. Their portfolio includes cutting-edge medical imaging systems, laboratory diagnostics, and digital health solutions that empower healthcare providers to deliver more precise and efficient patient care. With a strong focus on integrating AI and data-driven insights, Siemens Healthineers helps healthcare systems improve outcomes and operational efficiency. The company is committed to transforming healthcare by enabling earlier diagnoses, personalized treatments, and improving overall patient outcomes across the continuum of care.

Location 🇩🇪 Germany, Erlangen	Size View 35,158 employees
Revenue $ 500M – $ 1B	Industries Health Care, Medical, Medical Device, Health Diagnostics, Biotechnology, Neuroscience
	View Similar Companies

Want to see more biotechnology companies?

Things to Consider When Prospecting into Biotechnology Companies

Common Pain Points and Challenges for Companies in Biotech

Regulatory Hurdles

The biotechnology industry is highly regulated, with strict oversight from agencies like the FDA and EMA. Navigating complex regulatory frameworks is time-consuming and costly.

Why it’s a pain point:

Lengthy approval processes slow product development.
Expensive compliance measures increase operational costs.
Frequent changes in regulations require constant adaptation.

Sales Insight: Sales professionals can assist biotech companies by offering solutions that help streamline regulatory workflows. Emphasizing your ability to reduce time-to-market or lower compliance costs can be a key differentiator when selling into this industry.

High R&D Costs

Biotechnology companies often invest heavily in research and development, but the process of turning innovations into marketable products is expensive and uncertain.

Why it’s a pain point:

Long R&D cycles delay ROI.
High upfront investments are risky, especially with uncertain outcomes.
Need for specialized talent adds to costs.

Sales Insight: By understanding these financial constraints, sales professionals can position their solutions as cost-efficient and ROI-focused. Offering financing options or partnerships that lower upfront costs can resonate well with biotech decision-makers.

Intellectual Property (IP) Challenges

Biotechnology thrives on innovation, but securing and defending intellectual property is a critical and ongoing struggle for many companies.

Why it’s a pain point:

High legal fees associated with filing and protecting patents.
Risk of infringement disputes.
Patents expire, leading to competitive threats from generics.

Sales Insight: Sales teams should highlight any features that enhance IP protection or reduce the risk of infringement. Understanding the importance of IP security allows sales professionals to tailor solutions that safeguard a company’s competitive edge.

Talent Shortage

The biotechnology industry faces a shortage of skilled professionals, particularly in specialized roles such as molecular biology, bioinformatics, and genetic engineering.

Why it’s a pain point:

Hard-to-fill positions slow down innovation.
High competition for top talent drives up salary expectations.
Long recruitment processes strain project timelines.

Sales Insight: Sales professionals can provide value by offering solutions that optimize workforce productivity or reduce the dependency on hard-to-find talent. Highlight how your product can free up internal resources or streamline recruitment.

Funding Constraints

Biotechnology companies often depend on venture capital or government grants to fuel their innovation. Securing funding is highly competitive and unpredictable.

Why it’s a pain point:

Startups struggle to raise enough capital to bring products to market.
Heavy reliance on external investors or grants.
Economic downturns can dry up funding sources.

Sales Insight: Sales teams should demonstrate how their offerings can increase financial stability or make a business more attractive to investors. Solutions that accelerate time-to-revenue or lower operational costs will resonate in discussions about ROI.

Market Access Barriers

Biotechnology companies often struggle to enter new markets, whether due to regulatory differences, pricing challenges, or varying healthcare policies across countries.

Why it’s a pain point:

High market entry costs.
Complex international regulations.
Inconsistent reimbursement policies across regions.

Sales Insight: Sales professionals can highlight how their solutions simplify market access, whether through streamlining operations or offering expertise on local regulations. Positioning your product as a way to reduce the complexity of global expansion will appeal to biotech companies seeking growth.

Pricing Pressure from Healthcare Systems

As biotechnology products like biologics or gene therapies enter the market, they face intense scrutiny over pricing from healthcare providers and insurance companies.

Why it’s a pain point:

Pressure to justify high treatment costs.
Payers often limit reimbursement for expensive therapies.
Risk of government-imposed price caps.

Sales Insight: Sales professionals can tailor their pitch by focusing on cost-benefit analysis or value-based selling. Emphasize how your solution aligns with the industry’s pricing pressures by improving efficiency or reducing costs in the long run.

Public Perception and Ethical Concerns

Biotechnology companies frequently face public scrutiny, particularly regarding ethical issues related to genetic modification, cloning, or animal testing.

Why it’s a pain point:

Negative public opinion can lead to regulatory delays or stricter policies.
Ethical concerns can impact investor and customer confidence.
Public backlash may require additional PR efforts.

Sales Insight: Sales teams can frame their solutions as tools to enhance transparency or ensure ethical compliance. Showing an understanding of public and ethical concerns can build trust with biotech companies that prioritize corporate social responsibility.

Fast-Evolving Technology Landscape

Biotechnology is an innovation-driven field, but keeping up with rapid technological advancements is challenging.

Why it’s a pain point:

The risk of technological obsolescence is high.
Expensive upgrades or reinvestment are often required.
Continuous R&D is necessary to remain competitive.

Sales Insight: Sales professionals can position their products as adaptable and future-proof, helping companies stay ahead of industry shifts. Demonstrating how your solution integrates with the latest technology or simplifies adoption of new innovations can give your pitch an edge.

Supply Chain Vulnerabilities

Biotechnology companies depend on highly specialized supply chains for raw materials and equipment, making them vulnerable to disruptions.

Why it’s a pain point:

Supply shortages can halt production or delay R&D.
Dependency on a limited number of suppliers creates bottlenecks.
Quality control in the supply chain is critical and difficult to manage.

Sales Insight: Sales professionals can win over prospects by showing how their solutions mitigate supply chain risks. Offering flexible supply chain strategies or tech solutions that improve visibility and management can address this pain point directly.

Start finding new prospects that match your ICP

Key Decision-Makers and Influencers in Biotech

Key Departments

R&D (Research and Development)

Insight: R&D is central in biotech companies, focused on product development, innovation, and clinical research. Decision-makers prioritize tools that enhance research, speed up innovation, and ensure regulatory compliance.

Regulatory Affairs (Healthcare/Legal)

Insight: Regulatory Affairs teams ensure that all biotech products meet stringent regulatory standards like FDA or EMA. They require solutions that support compliance management, risk mitigation, and detailed reporting.

Procurement

Insight: Procurement handles sourcing of biotech-specific materials, equipment, and services. Their decisions focus on cost, supplier reliability, and technical alignment with highly specialized requirements.

Quality Control (QA)

Insight: Quality Control ensures that biotech products meet rigorous quality and safety standards. They seek solutions that enhance testing, ensure regulatory compliance, and maintain product integrity throughout the production lifecycle.

Sales

Insight: Sales in biotech focuses on healthcare professionals, hospitals, and regulatory bodies. Sales teams need tools that provide insights into complex customer needs, help manage data, and streamline communication with healthcare providers.

Marketing and Advertising

Insight: Marketing in biotech is responsible for positioning products in highly regulated markets. Their focus is on tools that offer data-driven insights, regulatory-compliant messaging, and customer engagement strategies.

Accounting and Finance

Insight: Accounting and finance teams evaluate the ROI of biotech investments, scrutinizing budgets, regulatory costs, and project feasibility. Their purchasing decisions center on the financial sustainability and scalability of solutions.

Insight: HR in biotech oversees talent acquisition for specialized roles like scientists and engineers. They need systems that help attract top talent and manage compliance with industry-specific regulations.

Operations

Insight: Operations teams in biotech manage the day-to-day activities of labs and production facilities. They look for tools that optimize workflows, reduce costs, and ensure the smooth running of research and production environments.

Procurement

Insight: This department is critical in sourcing specialized materials and ensuring partnerships with reliable suppliers, focusing on cost-effectiveness and technical requirements.

Seniority Level

C-level Executives (e.g., Chief Scientific Officer, Chief Medical Officer)

Insight: C-level executives make strategic decisions that impact the entire biotech company, especially regarding long-term R&D investments, compliance, and partnerships. They prioritize solutions that support scalability, reduce time-to-market, and ensure regulatory success.

Vice Presidents (VP)

Insight: VPs in biotech, particularly in R&D, clinical operations, and regulatory affairs, are responsible for departmental strategies. They play a key role in evaluating how new solutions align with long-term scientific goals and compliance needs.

Directors

Insight: Directors manage teams within R&D, regulatory, and QA departments, among others. They are often hands-on in the selection of tools and services, evaluating how well a solution fits into existing workflows and meets operational objectives.

Managers

Insight: Managers are involved in the day-to-day operations, from laboratory management to overseeing clinical trials. They often initiate purchasing decisions, providing key insights into operational needs, such as equipment reliability or software usability.

Not joined Surfe yet? Sign up to Surfe today

Buying Processes and Behaviors in Biotechnology

Risk aversion and regulatory compliance

Biotech companies are extremely cautious in their purchasing due to the heavy regulation and risks associated with their work.

Purchases must meet stringent regulatory standards (e.g., FDA, EMA) and safety guidelines.
Risk of failure or non-compliance can have serious financial and legal consequences.
Buyers often look for suppliers with a proven track record in the biotech space.

How to leverage: Highlight your product’s compliance with relevant regulations and emphasize certifications or case studies showing its successful use in similar biotech settings. Build trust by offering a guarantee or clear evidence of risk mitigation.

Long sales cycles driven by research

Purchases in biotech are often tied to the slow nature of research, trials, and product development.

Buyers require time to evaluate new technologies and integrate them into ongoing R&D.
Multiple departments, from R&D to procurement and legal, typically get involved in decision-making.
Trials or demonstrations may be required to prove efficacy before purchase.

How to leverage: Be patient and focus on building long-term relationships. Offer trial periods, product demonstrations, and detailed case studies to show how your solution supports ongoing research. Communicate consistently to nurture trust throughout the lengthy decision-making process.

Collaborative decision-making

Biotech companies often involve cross-functional teams when making purchasing decisions.

Purchasing decisions usually require input from R&D, operations, legal, and procurement teams.
Final approvals may involve senior management, especially for larger investments.
Each department evaluates the product or service from its unique perspective (scientific validity, operational fit, legal risk).

How to leverage: Engage with multiple stakeholders early in the process. Tailor your messaging to address the specific needs of each department. Position your solution as an asset that meets both scientific and operational goals, and work on securing champions within the company.

Focus on innovation and cutting-edge solutions

The biotechnology industry is driven by a need for innovative, cutting-edge solutions that push scientific boundaries.

Companies prefer working with suppliers who offer novel technologies that can give them a competitive edge.
Buyers seek solutions that improve efficiency, enhance research outcomes, or reduce time to market.

How to leverage: Emphasize the innovative aspects of your product and how it differentiates from older or standard technologies. Share case studies that demonstrate how your solution has contributed to breakthroughs or efficiency improvements in similar biotech companies.

Cost sensitivity despite high budgets

While biotech companies may have large R&D budgets, they remain cost-sensitive, especially for capital-intensive projects.

Purchases need to show clear ROI, often tied to speeding up research or reducing operational costs.
Budget constraints can still affect decision timelines, with high scrutiny over large expenditures.

How to leverage: Provide a clear cost-benefit analysis that ties the value of your product to improved research outcomes, efficiency gains, or long-term cost savings. Consider offering flexible pricing models or phased implementation plans to reduce the immediate financial burden.

Preference for long-term partnerships

Biotech companies prefer forming long-term partnerships with vendors who understand their specific needs and can provide ongoing support.

The complexity of biotech operations makes it more efficient to stick with trusted, reliable suppliers.
Strong relationships allow for better collaboration on future projects and innovations.

How to leverage: Position yourself as a partner rather than just a vendor. Offer customized support packages, regular check-ins, and future product updates to show your commitment to the company’s success over the long haul.

Data-driven decision-making

Data and evidence are crucial in the biotech industry, where purchases often need to be scientifically validated.

Buyers require hard data, studies, or trials to demonstrate the value and performance of new products.
Analytical tools or products that help generate or interpret data are highly valued.

How to leverage: Provide robust data to back up your claims, whether through case studies, independent research, or user testimonials. Offer detailed white papers or product testing results to satisfy the need for evidence-based decision-making.

Customization and flexibility in offerings

Biotech companies often require solutions that can be tailored to their specific research needs or operational workflows.

Off-the-shelf products may not always meet the exact requirements of a particular project or company.
Customization and flexibility in pricing, support, or product features are often expected.

How to leverage: Offer customization options or flexible configurations to meet the unique needs of biotech companies. Be prepared to collaborate closely with their teams to ensure that your solution integrates seamlessly with their existing processes.

Ethical considerations

Given the sensitive nature of biotech work, ethical concerns play a role in purchasing decisions, particularly around sourcing and sustainability.

Companies need to ensure that the products or services they use align with ethical standards and practices.
This is especially important in areas like genetic research, clinical trials, and environmental impact.

How to leverage: Highlight your commitment to ethical practices, including transparency in sourcing, environmental responsibility, and adherence to ethical research standards. This can help build trust and align your company with the values of biotech firms.

Scalability and future-proofing

Biotech companies need solutions that not only meet current needs but can scale and adapt as research or production scales up.

Buyers look for products that can grow with their company, avoiding the need for frequent replacements or upgrades.
Future-proof solutions help mitigate the risk of obsolescence as technology advances.

How to leverage: Showcase how your product can scale and remain relevant as biotech companies grow or as their research evolves. Offer updates or modular add-ons that keep your solution adaptable over time.

Not joined Surfe yet? Get 20 free credits

Prospecting Tips for Selling to Biotech Companies

Understand the Importance of Innovation in Biotech

Biotech companies thrive on innovation, with constant pressure to develop new drugs, therapies, and technologies. They need tools that can streamline research, speed up trials, and improve collaboration across teams. When prospecting, show that you understand the industry’s fast-paced, innovation-driven environment and how your product can help them stay competitive.

Tip: Highlight how your solution can support cutting-edge research, improve data analysis, or enhance collaboration, helping them innovate faster and more effectively.

Acknowledge Long Sales Cycles

The biotech industry is known for its lengthy development and approval processes, especially when it comes to drug development and clinical trials. Sales cycles for new technology can also be long due to regulatory requirements, budgeting, and thorough vetting. Be prepared for a long prospecting journey, and emphasize how your solution can add value at every stage.

Tip: During outreach, show patience and provide value at each touchpoint, offering content that addresses specific stages of the development process—such as scaling production or regulatory approval.

Emphasize Regulatory Support

Regulatory compliance is a critical concern in biotech, given the industry’s heavy regulation. Companies must navigate frameworks like FDA approval in the U.S. or EMA in Europe. Offering a solution that supports compliance, whether it’s in drug development, clinical trials, or manufacturing, can give you an edge.

Tip: Mention how your product can help with regulatory challenges, such as streamlining approval processes or ensuring data integrity throughout clinical trials and manufacturing.

Showcase Scalability

Biotech companies often go through rapid growth cycles, moving from small teams focused on R&D to larger operations during manufacturing or after a successful trial. They need scalable solutions that can grow with them, without causing disruptions.

Tip: Emphasize the scalability of your solution and how it can support a company’s growth trajectory, from initial research phases through commercialization.

Focus on Collaboration and Partnerships

The biotech industry is built on partnerships between academia, research institutions, and pharmaceutical companies. Effective collaboration is key to speeding up innovation and bringing products to market. If your product facilitates better communication or collaboration, this can be a compelling selling point.

Tip: Position your solution as one that enhances communication and collaboration across teams, institutions, or geographies, enabling biotech firms to work more efficiently with partners.

Book a demo

100,199

Want to see more biotechnology companies?

Things to Consider When Prospecting into Biotechnology Companies

Common Pain Points and Challenges for Companies in Biotech

Start finding new prospects that match your ICP

Key Decision-Makers and Influencers in Biotech

Key Departments

Seniority Level

Not joined Surfe yet? Sign up to Surfe today

Buying Processes and Behaviors in Biotechnology

Not joined Surfe yet? Get 20 free credits

Prospecting Tips for Selling to Biotech Companies

Need prospects?

Top 10 Biotechnology Companies — a guide for sales

Want to see more biotechnology companies?

Things to Consider When Prospecting into Biotechnology Companies

Common Pain Points and Challenges for Companies in Biotech

Start finding new prospects that match your ICP

Key Decision-Makers and Influencers in Biotech

Key Departments

Seniority Level

Not joined Surfe yet? Sign up to Surfe today

Buying Processes and Behaviors in Biotechnology

Not joined Surfe yet? Get 20 free credits

Prospecting Tips for Selling to Biotech Companies